Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocardia Inc (NQ: BCDA )

2.000 UNCHANGED
Streaming Delayed Price Updated: 9:35 AM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,660
Open 2.000
Bid (Size) 2.000 (2)
Ask (Size) 2.040 (3)
Prev. Close 2.000
Today's Range 2.000 - 2.000
52wk Range 1.100 - 2.850
Shares Outstanding 17,841,927
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
BioCardia Outlines Detailed Cell Therapy Data From Heart Failure Study
 
Via Benzinga
$1 Million Bet On BioCardia? Check Out These 4 Penny Stocks Insiders Are Buying
The Dow Jones settled higher on Tuesday after recording losses for four straight sessions. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga

Performance

YTD
-7.83%
-7.83%
1 Month
-13.04%
-13.04%
3 Month
+11.73%
+11.73%
6 Month
+9.89%
+9.89%
1 Year
-5.66%
-5.66%

More News

Read More
BioCardia's Return On Capital Employed Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
BioCardia Announces FDA Approval of IND Application for Allogeneic NK1R+ Human Mesenchymal Stem Cells for Ischemic Heart Failure
From BioCardia, Inc.
Via Business Wire
BioCardia's Heart Failure Cell Therapy Shows 100% Survival At Two Years
Via Benzinga
Recap: BioCardia Q2 Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2022
Via Benzinga
Earnings Preview For BioCardia
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
FDA Approves BioCardia's Phase 1 Trial With Cell Therapy In COVID-19, Shares Jump
Via Benzinga
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Via Benzinga
BioCardia Earnings Preview
Via Benzinga
Executives Buy Around $4M Of 5 Penny Stocks
Via Benzinga
Recap: BioCardia Q1 Earnings
Via Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
Via Benzinga
Earnings Preview For BioCardia
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Follow the Insiders and Buy the Dip in These 3 Stocks
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Looking Into BioCardia's Return On Capital Employed
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.